Treatment of Expiratory Airway Collapse Disease
The treatment of expiratory airway collapse disease should follow a stepwise approach, beginning with conservative measures and advancing to more invasive interventions for severe cases that significantly impact quality of life.
Initial Assessment and Classification
- Expiratory central airway collapse (ECAC) encompasses tracheobronchomalacia (TBM) and excessive dynamic airway collapse (EDAC), characterized by excessive narrowing of the airway lumen during exhalation 1, 2
- Diagnosis should be confirmed via dynamic flexible bronchoscopy (gold standard) and/or dynamic CT imaging 1
- Severity is typically classified based on the degree of airway collapse, with severe collapse defined as >90% reduction in airway lumen 3
First-Line Management
- Treatment of coexisting conditions is essential, including COPD, asthma, gastroesophageal reflux disease, and vocal cord dysfunction 4
- Supportive treatment includes:
Airway Clearance Techniques
- Forced expiratory technique (huffing) is recommended for patients with COPD to enhance secretion clearance without excessive effort 5
- Manually assisted cough should be considered for patients with expiratory muscle weakness but avoided in patients with airflow obstruction from COPD as it may be detrimental 5
- Body positioning and mobilization can enhance airway secretion clearance 5
Positive Pressure Ventilation
- Continuous positive airway pressure (CPAP) is recommended as a non-invasive approach to maintain airway patency during exhalation 4, 6
- For patients with severe symptoms, noninvasive positive pressure ventilation (NIPPV) may be beneficial, though some patients may not tolerate it 6
Pharmacological Management
- Bronchodilators may have variable effects depending on the specific mechanism of airway collapse:
- In collapsible trachea, bronchoconstrictor agents may increase airway smooth muscle tone and improve airway stiffness 5
- In dynamic airway collapse due to small airway obstruction, bronchodilators may relieve obstruction and decrease expiratory pressure effort 5
- Caution is advised as bronchodilators may worsen dynamic airway collapse in some cases of fixed small airway obstruction 5
- Long-acting bronchodilators (LABA, LAMA) should be considered for patients with concurrent COPD 5, 7
Advanced Interventions for Severe Cases
For patients with severe central airway collapse (>90%) and severe symptoms that significantly impact quality of life, corrective treatments should be considered:
Temporary stent trial:
Tracheobronchoplasty (TBP):
Permanent stenting:
Special Considerations
- Management should be coordinated by a multidisciplinary airway team in specialized centers with experience in treating this condition 4
- Patients with respiratory failure due to ECAC may require mechanical ventilation and should be evaluated for possible stent placement to facilitate weaning 6
- Anesthetic management for patients undergoing stent placement or tracheobronchoplasty is complex and requires special considerations 3, 2
Treatment Algorithm
- Confirm diagnosis with dynamic bronchoscopy or CT imaging
- Treat coexisting conditions and implement supportive care
- Trial appropriate airway clearance techniques and CPAP
- For severe symptoms despite conservative management, consider stent trial
- Based on stent trial results and surgical candidacy:
- Positive trial + good surgical candidate → Tracheobronchoplasty
- Positive trial + poor surgical candidate → Permanent stenting
- Negative trial → Continue conservative management